{"id":840187,"date":"2025-04-22T16:13:12","date_gmt":"2025-04-22T20:13:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/"},"modified":"2025-04-22T16:13:12","modified_gmt":"2025-04-22T20:13:12","slug":"elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/","title":{"rendered":"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29"},"content":{"rendered":"
\n

SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia\u2019s Chief Scientific Officer, will participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on Tuesday, April 29, 2025.<\/p>\n

\n Chardan’s Data & Regulatory Catalysts \u2013 Navigating an Evolving Landscape \u2013 Virtual<\/strong>
\n
\n Format:<\/strong>\u00a0Fireside Chat
Date and Time:<\/strong>\u00a0Tuesday, April 29, 2025, 11:00 a.m. ET (8:00 a.m. PT)
Webcast:<\/strong>\u00a0Click Here<\/a><\/p>\n

A live and archived webcast of the fireside chat will be available in the \u201cInvestors\u201d section of the Elutia website at\u00a0http:\/\/investors.elutia.com\/<\/a>.<\/p>\n

\n About Elutia<\/strong>
\n
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia\u2019s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com<\/a>.<\/p>\n

\n Investors:<\/strong>
\n
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com<\/a><\/p>\n

This press release was published by a CLEAR\u00ae Verified individual.<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia\u2019s Chief Scientific Officer, will participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on Tuesday, April 29, 2025. Chardan’s Data & Regulatory Catalysts \u2013 Navigating an Evolving Landscape \u2013 Virtual Format:\u00a0Fireside ChatDate and Time:\u00a0Tuesday, April 29, 2025, 11:00 a.m. ET (8:00 a.m. PT)Webcast:\u00a0Click Here A live and archived webcast of the fireside chat will be available in the \u201cInvestors\u201d section of the Elutia website at\u00a0http:\/\/investors.elutia.com\/. About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in … <\/p>\n

Continue reading “Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-840187","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nElutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia\u2019s Chief Scientific Officer, will participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on Tuesday, April 29, 2025. Chardan’s Data & Regulatory Catalysts \u2013 Navigating an Evolving Landscape \u2013 Virtual Format:\u00a0Fireside ChatDate and Time:\u00a0Tuesday, April 29, 2025, 11:00 a.m. ET (8:00 a.m. PT)Webcast:\u00a0Click Here A live and archived webcast of the fireside chat will be available in the \u201cInvestors\u201d section of the Elutia website at\u00a0http:\/\/investors.elutia.com\/. About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in … Continue reading "Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-22T20:13:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29\",\"datePublished\":\"2025-04-22T20:13:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/\"},\"wordCount\":180,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/\",\"name\":\"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=\",\"datePublished\":\"2025-04-22T20:13:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/","og_locale":"en_US","og_type":"article","og_title":"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29 - Market Newsdesk","og_description":"SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (\u201cElutia\u201d), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia\u2019s Chief Scientific Officer, will participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on Tuesday, April 29, 2025. Chardan’s Data & Regulatory Catalysts \u2013 Navigating an Evolving Landscape \u2013 Virtual Format:\u00a0Fireside ChatDate and Time:\u00a0Tuesday, April 29, 2025, 11:00 a.m. ET (8:00 a.m. PT)Webcast:\u00a0Click Here A live and archived webcast of the fireside chat will be available in the \u201cInvestors\u201d section of the Elutia website at\u00a0http:\/\/investors.elutia.com\/. About Elutia Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in … Continue reading \"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-22T20:13:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29","datePublished":"2025-04-22T20:13:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/"},"wordCount":180,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/","name":"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=","datePublished":"2025-04-22T20:13:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjcyNSM2ODk4OTYwIzIxNzk3MDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/elutia-to-participate-in-chardans-trending-issues-in-drug-development-conference-series-on-april-29\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Elutia to Participate in Chardan\u2019s Trending Issues in Drug Development Conference Series on April 29"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=840187"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/840187\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=840187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=840187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=840187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}